H 89 2HCl
Catalog No. A11935
H 89 dihydrochloride是一种可渗透细胞的,选择性的,可逆的,具有ATP竞争性的有效蛋白激酶抑制剂。
- Guo Q, .et al. Antineuropathic pain actions of Wu-tou decoction resulted from the increase of neurotrophic factor and decrease of CCR5 expression in primary rat glial cells, Biomed Pharmacother, 2020, Mar;123:109812 PMID: 31945696
- Y Kaibori, .et al. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity, the FASEB Journal, 2019, Jan 22:fj201801519RR PMID: 30668924
Catalog Num | A11935 |
---|---|
M. Wt | 519.3 |
Formula | C20H20BrN3O2S.2HCl |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 127243-85-0, 130964-39-5 |
Synonyms | H89 2HCl |
SMILES | C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNC/C=C/C3=CC=C(C=C3)Br |
H 89 dihydrochloride是一种可渗透细胞的,选择性的,可逆的,具有ATP竞争性的有效蛋白激酶抑制剂。
In vitro (25°C) | DMSO | 96 mg/mL (184.86 mM) | |
Water | 6 mg/mL (11.55 mM) | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.26 mL | 96.28 mL | 192.57 mL |
0.5 mM | 3.85 mL | 19.26 mL | 38.51 mL |
1 mM | 1.93 mL | 9.63 mL | 19.26 mL |
5 mM | 0.39 mL | 1.93 mL | 3.85 mL |
*The above data is based on the productmolecular weight 519.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.